Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its newly established subsidiary SBB Residential Property AB entering into a capital raise agreement with an investment fund managed by Morgan Stanley Real Estate Inve
Mandate

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its newly established subsidiary SBB Residential Property AB entering into a capital raise agreement with an investment fund managed by Morgan Stanley Real Estate Investing (“MSREI”).

July 25, 2023 Capital Markets and Public M&A Employment and Benefits Banking and Finance IT, Telecommunications and Outsourcing Data protection and processing of personal data

Pursuant to the agreement, SBB Residential Property AB will issue SEK 2.36 billion of preference shares to MSREI. The preference shares will be issued by an entity to be named SBB Residential Property AB forming a new group within SBB.

Following the transaction, MSREI will hold a minority stake in SBB Residential Property AB. The transaction is subject to customary closing conditions but not competition clearance. Closing will occur as soon as all closing conditions have been fulfilled, which is expected to occur around mid August 2023.

Vinge’s team consisted mainly of Mikael Ståhl, Jesper Schönbeck, Rikard Lindahl, Niclas Winnberg, Helena Göransson, Ulrich Ziche, Maria Dahlin Kolvik, Kristoffer Larsson, Frida Ställborn, Joel Magnusson, Kamyar Najmi, Nour Makie, Ida Redander and Filip Magnusson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026